Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ravi Salgia

Showing results (251-260 of 528) with videos related to

Pageof 53
Sort By:
Oncotarget|May 3, 2018
2'-Hydroxyflavanone effectively targets RLIP76-mediated drug transport and regulates critical signaling networks in breast cancerLokesh Dalasanur Nagaprashantha, Jyotsana Singhal, Hongzhi Li, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|March 22, 2015
c-Abl mediated tyrosine phosphorylation of paxillin regulates LPS-induced endothelial dysfunction and lung injuryPanfeng Fu, Peter V Usatyuk, Abhishek Lele, et al.
Cancers|April 14, 2025
Treatment Approaches for Oligoprogressive Non-Small Cell Lung Cancer: A Review of Ablative RadiotherapyWilliam Gombrich, Nicholas Eustace, Yufei Liu, et al.
Critical Reviews in Oncology/Hematology|February 5, 2026
Emerging Trends and Treatment Strategies in Ovarian Cancer: A Comprehensive ReviewB Madhu Krishna, Pankaj Garg, Sravani Ramisetty, et al.
Journal of Thoracic Disease|November 4, 2020
Role of immunotherapy and co-mutations on KRAS-mutant non-small cell lung cancer survivalIdoroenyi Amanam, Isa Mambetsariev, Rohan Gupta, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 26, 2022
Machine learning to refine prognostic and predictive nodal burden thresholds for post-operative radiotherapy in completely resected stage III-N2 non-small cell lung cancerReza Zarinshenas, Colton Ladbury, Heather McGee, et al.
Oncotarget|March 9, 2022
Correction: 2'-Hydroxyflavanone effectively targets RLIP76-mediated drug transport and regulates critical signaling networks in breast cancerLokesh Dalasanur Nagaprashantha, Jyotsana Singhal, Hongzhi Li, et al.
Cureus|August 11, 2021
Elevated Eosinophil Count Following Pembrolizumab Treatment for Non-Small Cell Lung CancerAngel R Baroz, Isa Mambetsariev, Jeremy Fricke, et al.
Journal of Clinical Medicine|July 14, 2023
Clinical Network Systems Biology: Traversing the Cancer MultiverseIsa Mambetsariev, Jeremy Fricke, Stephen B Gruber, et al.
Cancer Treatment Reviews|April 21, 2017
The accelerated path of ceritinib: Translating pre-clinical development into clinical efficacyTony S K Mok, Lucio Crino, Enriqueta Felip, et al.
Pageof 53

Showing results (251-260 of 528) with videos related to

Sort By:
Pageof 53
Oncotarget|May 3, 2018
2'-Hydroxyflavanone effectively targets RLIP76-mediated drug transport and regulates critical signaling networks in breast cancerLokesh Dalasanur Nagaprashantha, Jyotsana Singhal, Hongzhi Li, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|March 22, 2015
c-Abl mediated tyrosine phosphorylation of paxillin regulates LPS-induced endothelial dysfunction and lung injuryPanfeng Fu, Peter V Usatyuk, Abhishek Lele, et al.
Cancers|April 14, 2025
Treatment Approaches for Oligoprogressive Non-Small Cell Lung Cancer: A Review of Ablative RadiotherapyWilliam Gombrich, Nicholas Eustace, Yufei Liu, et al.
Critical Reviews in Oncology/Hematology|February 5, 2026
Emerging Trends and Treatment Strategies in Ovarian Cancer: A Comprehensive ReviewB Madhu Krishna, Pankaj Garg, Sravani Ramisetty, et al.
Journal of Thoracic Disease|November 4, 2020
Role of immunotherapy and co-mutations on KRAS-mutant non-small cell lung cancer survivalIdoroenyi Amanam, Isa Mambetsariev, Rohan Gupta, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 26, 2022
Machine learning to refine prognostic and predictive nodal burden thresholds for post-operative radiotherapy in completely resected stage III-N2 non-small cell lung cancerReza Zarinshenas, Colton Ladbury, Heather McGee, et al.
Oncotarget|March 9, 2022
Correction: 2'-Hydroxyflavanone effectively targets RLIP76-mediated drug transport and regulates critical signaling networks in breast cancerLokesh Dalasanur Nagaprashantha, Jyotsana Singhal, Hongzhi Li, et al.
Cureus|August 11, 2021
Elevated Eosinophil Count Following Pembrolizumab Treatment for Non-Small Cell Lung CancerAngel R Baroz, Isa Mambetsariev, Jeremy Fricke, et al.
Journal of Clinical Medicine|July 14, 2023
Clinical Network Systems Biology: Traversing the Cancer MultiverseIsa Mambetsariev, Jeremy Fricke, Stephen B Gruber, et al.
Cancer Treatment Reviews|April 21, 2017
The accelerated path of ceritinib: Translating pre-clinical development into clinical efficacyTony S K Mok, Lucio Crino, Enriqueta Felip, et al.
Pageof 53